Clinical Trial Update: Comparison of Biomatrix and Orsiro Drug Eluting Stent [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Biomatrix and Orsiro drug-eluting stents in coronary artery disease and myocardial ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• Biomatrix
• Orsiro (Sirolimus-eluting stent)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Coronary Artery Disease, Myocardial Ischemia | Phase 4 | Status: COMPLETED